Terms: = Liver cancer AND CDKN2C, P42773, 1031, ENSG00000123080, INK4C, p18, p18-INK4C
59 results:
1. Individual Participant Data Meta-Analysis of LR-5 in LI-RADS Version 2018 versus Revised LI-RADS for Hepatocellular Carcinoma Diagnosis.
Goins SM; Jiang H; van der Pol CB; Salameh JP; Lam E; Adamo RG; McInnes MDF; Costa AF; Tang A; Alhasan AS; Allen BC; Reiner CS; Clarke C; Cerny M; Wang J; Choi SH; Fraum TJ; Ludwig DR; Song B; Joo I; Kang Z; Kierans AS; Kim SY; Kwon H; Ronot M; Podgórska J; Rosiak G; Song JS; Bashir MR
Radiology; 2023 Dec; 309(3):e231656. PubMed ID: 38112549
[TBL] [Abstract] [Full Text] [Related]
2. Time from immune checkpoint inhibitor to sotorasib use correlates with risk of hepatotoxicity in non-small cell lung cancer: A brief report.
Desai A; Rakshit S; Bansal R; Ashara Y; Potter A; Manochakian R; Lou Y; Zhao Y; Ernani V; Savvides P; Schwecke A; Moffett N; Hocum C; Leventakos K; Adjei A; Marks R; Molina J; Mansfield AS; Chen ZM; Dimou A
Cancer Treat Res Commun; 2023; 36():100743. PubMed ID: 37531736
[TBL] [Abstract] [Full Text] [Related]
3. Functionalized pyrite nanozyme probe and imprinted polymer modified with hydrophilic layer for rapid colorimetric analysis of glycoprotein in serum.
Yang YS; Yu SS; Chen MY; Zuo D; Luo Y; Qiang T; Ma H; Yang XF; Ma YB; Wang XH; Zhao ZY; Dong LY
Talanta; 2023 Aug; 261():124665. PubMed ID: 37209585
[TBL] [Abstract] [Full Text] [Related]
4. Effectiveness and safety of radiotherapy plus programmed death-1 inhibitors and lenvatinib in patients with advanced biliary tract carcinoma: a real-world study.
Wang Y; Yang X; Wang Y; Xue J; Zhang N; Yang X; Cong N; Zhang J; Zhu C; Zhang L; Hou X; Zhao H
Cancer Immunol Immunother; 2023 Jul; 72(7):2197-2204. PubMed ID: 36856834
[TBL] [Abstract] [Full Text] [Related]
5. Digital Droplet PCR for Detection and Quantitation of Hepatitis Delta Virus.
Xu L; Zhang X; Cao Y; Fan Z; Tian Y; Zou H; Ma Y; Duan Z; Ren F
Clin Transl Gastroenterol; 2022 Jul; 13(7):e00509. PubMed ID: 35905419
[TBL] [Abstract] [Full Text] [Related]
6. Nutritional status in patients with hepatocellular carcinoma: Potential relevance for clinical outcome.
van Dijk AM; Coppens BJP; van Beers MA; Bruins Slot AS; Verstraete CJR; de Bruijne J; Vleggaar FP; van Erpecum KJ
Eur J Intern Med; 2022 Oct; 104():80-88. PubMed ID: 35902333
[TBL] [Abstract] [Full Text] [Related]
7. INK4 cyclin-dependent kinase inhibitors as potential prognostic biomarkers and therapeutic targets in hepatocellular carcinoma.
Liu H; Jia S; Guo K; Li R
Biosci Rep; 2022 Jul; 42(7):. PubMed ID: 35771229
[TBL] [Abstract] [Full Text] [Related]
8. Molecular deciphering of primary liver neuroendocrine neoplasms confirms their distinct existence with foregut-like profile.
de Mestier L; Nicolle R; Poté N; Rebours V; Cauchy F; Hentic O; Maire F; Ronot M; Lebtahi R; Sauvanet A; Paradis V; Ruszniewski P; Couvelard A; Cros J
J Pathol; 2022 Sep; 258(1):58-68. PubMed ID: 35681273
[TBL] [Abstract] [Full Text] [Related]
9. [Adherence to adjuvant with therapy imatinib in patients with gastrointestinal stromal tumor: a national multi-center cross-sectional study].
Zhang P; Zhang J; Zhang B; Yang WC; Hu JB; Sun XF; Zhai G; Qian HR; Li Y; Xu H; Feng F; Wu XY; Liu HL; Liu HJ; Qiu HB; Wu XJ; Zhou YB; Shen KT; Kou YW; Fu Y; Jie ZG; Zou XM; Cao H; Gao ZD; Tao KX
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep; 24(9):775-782. PubMed ID: 34530558
[No Abstract] [Full Text] [Related]
10. Downregulated miRNA-22-3p promotes the progression and leads to poor prognosis of hepatocellular carcinoma through targeting cdkn2c.
Kong D; Wang X; Wang X; Wang Z; Wang F
J BUON; 2021; 26(2):409-417. PubMed ID: 34076987
[TBL] [Abstract] [Full Text] [Related]
11. Left-side vs. right-side hepatectomy for hilar cholangiocarcinoma: a meta-analysis.
Wu W; Cheng Q; Chen J; Chen D; Feng X; Wu J
World J Surg Oncol; 2021 Apr; 19(1):107. PubMed ID: 33838682
[TBL] [Abstract] [Full Text] [Related]
12. Discovery of Novel and Highly Potent Resorcinol Dibenzyl Ether-Based PD-1/PD-L1 Inhibitors with Improved Drug-like and Pharmacokinetic Properties for cancer Treatment.
Cheng B; Wang W; Niu X; Ren Y; Liu T; Cao H; Wang S; Tu Y; Chen J; Liu S; Yang X; Chen J
J Med Chem; 2020 Dec; 63(24):15946-15959. PubMed ID: 33264007
[TBL] [Abstract] [Full Text] [Related]
13. Association between five types of Tumor Necrosis Factor-α gene polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Wungu CDK; Ariyanto FC; Prabowo GI; Soetjipto ; Handajani R
BMC Cancer; 2020 Nov; 20(1):1134. PubMed ID: 33228594
[TBL] [Abstract] [Full Text] [Related]
14. Effect of sarcopenia on systemic targeted therapy response in patients with advanced hepatocellular carcinoma.
Qayyum A; Bhosale P; Aslam R; Avritscher R; Ma J; Pagel MD; Sun J; Mohamed Y; Rashid A; Beretta L; Kaseb AO
Abdom Radiol (NY); 2021 Mar; 46(3):1008-1015. PubMed ID: 32974761
[TBL] [Abstract] [Full Text] [Related]
15. Mac-2 binding protein glycosylation isomer as a novel predictive biomarker for patient survival after hepatitis C virus eradication by DAAs.
Nakagawa M; Nawa N; Takeichi E; Shimizu T; Tsuchiya J; Sato A; Miyoshi M; Kawai-Kitahata F; Murakawa M; Nitta S; Itsui Y; Azuma S; Kakinuma S; Fujiwara T; Watanabe M; Tanaka Y; Asahina Y;
J Gastroenterol; 2020 Oct; 55(10):990-999. PubMed ID: 32770465
[TBL] [Abstract] [Full Text] [Related]
16. A genome-wide gain-of-function screen identifies cdkn2c as a HBV host factor.
Eller C; Heydmann L; Colpitts CC; El Saghire H; Piccioni F; Jühling F; Majzoub K; Pons C; Bach C; Lucifora J; Lupberger J; Nassal M; Cowley GS; Fujiwara N; Hsieh SY; Hoshida Y; Felli E; Pessaux P; Sureau C; Schuster C; Root DE; Verrier ER; Baumert TF
Nat Commun; 2020 Jun; 11(1):2707. PubMed ID: 32483149
[TBL] [Abstract] [Full Text] [Related]
17. The CCR5 antagonist maraviroc causes remission of pancreatic cancer liver metastasis in nude rats based on cell cycle inhibition and apoptosis induction.
Huang H; Zepp M; Georges RB; Jarahian M; Kazemi M; Eyol E; Berger MR
Cancer Lett; 2020 Apr; 474():82-93. PubMed ID: 31954769
[TBL] [Abstract] [Full Text] [Related]
18. Aflatoxin Exposure from Milk in Rural Kenya and the Contribution to the Risk of liver cancer.
Sirma AJ; Makita K; Grace D; Senerwa D; Lindahl JF
Toxins (Basel); 2019 Aug; 11(8):. PubMed ID: 31405092
[TBL] [Abstract] [Full Text] [Related]
19. Dietary inflammatory index and cancer risk in the elderly: A pooled-analysis of Italian case-control studies.
Accardi G; Shivappa N; Di Maso M; Hébert JR; Fratino L; Montella M; La Vecchia C; Caruso C; Serraino D; Libra M; Polesel J
Nutrition; 2019; 63-64():205-210. PubMed ID: 31029049
[TBL] [Abstract] [Full Text] [Related]
20. Safety and technical feasibility of percutaneous ablation for lymph node metastases of hepatocellular carcinoma.
Yuan Z; Xing A; Zheng J; Li W
Int J Hyperthermia; 2019 Jan; 36(1):160-168. PubMed ID: 30776925
[TBL] [Abstract] [Full Text] [Related]
[Next]
